162 related articles for article (PubMed ID: 20023394)
1. Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure.
Huang Y; Chuang AY; Romano RA; Liégeois NJ; Sinha S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2010 Jan; 9(2):328-38. PubMed ID: 20023394
[TBL] [Abstract][Full Text] [Related]
2. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
[TBL] [Abstract][Full Text] [Related]
3. Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells.
Huang Y; Ratovitski EA
Aging (Albany NY); 2010 Dec; 2(12):959-68. PubMed ID: 21191146
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation.
Huang Y; Ratovitski EA
J Biol Chem; 2010 Dec; 285(53):41422-31. PubMed ID: 20959455
[TBL] [Abstract][Full Text] [Related]
5. ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.
Huang Y; Sen T; Nagpal J; Upadhyay S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2008 Sep; 7(18):2846-55. PubMed ID: 18769144
[TBL] [Abstract][Full Text] [Related]
6. Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.
Huang Y; Chuang A; Hao H; Talbot C; Sen T; Trink B; Sidransky D; Ratovitski E
Cell Death Differ; 2011 Jul; 18(7):1220-30. PubMed ID: 21274007
[TBL] [Abstract][Full Text] [Related]
7. DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation.
Sen T; Sen N; Brait M; Begum S; Chatterjee A; Hoque MO; Ratovitski E; Sidransky D
Cancer Res; 2011 Feb; 71(3):1167-76. PubMed ID: 21266360
[TBL] [Abstract][Full Text] [Related]
8. Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.
Huang Y; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Mar; 11(6):1247-59. PubMed ID: 22356768
[TBL] [Abstract][Full Text] [Related]
9. Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death.
Ratovitski EA
FEBS Lett; 2013 Aug; 587(16):2536-41. PubMed ID: 23831023
[TBL] [Abstract][Full Text] [Related]
10. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha.
Chatterjee A; Upadhyay S; Chang X; Nagpal JK; Trink B; Sidransky D
Cell Cycle; 2008 May; 7(9):1231-7. PubMed ID: 18418053
[TBL] [Abstract][Full Text] [Related]
11. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
[TBL] [Abstract][Full Text] [Related]
12. RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.
Fomenkov A; Zangen R; Huang YP; Osada M; Guo Z; Fomenkov T; Trink B; Sidransky D; Ratovitski EA
Cell Cycle; 2004 Oct; 3(10):1285-95. PubMed ID: 15467455
[TBL] [Abstract][Full Text] [Related]
13. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.
Huang Y; Chuang AY; Ratovitski EA
Cell Cycle; 2011 Nov; 10(22):3938-47. PubMed ID: 22071691
[TBL] [Abstract][Full Text] [Related]
14. SATB2 augments ΔNp63α in head and neck squamous cell carcinoma.
Chung J; Lau J; Cheng LS; Grant RI; Robinson F; Ketela T; Reis PP; Roche O; Kamel-Reid S; Moffat J; Ohh M; Perez-Ordonez B; Kaplan DR; Irwin MS
EMBO Rep; 2010 Oct; 11(10):777-83. PubMed ID: 20829881
[TBL] [Abstract][Full Text] [Related]
15. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.
Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C
Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882
[TBL] [Abstract][Full Text] [Related]
16. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer.
Wu G; Osada M; Guo Z; Fomenkov A; Begum S; Zhao M; Upadhyay S; Xing M; Wu F; Moon C; Westra WH; Koch WM; Mantovani R; Califano JA; Ratovitski E; Sidransky D; Trink B
Cancer Res; 2005 Feb; 65(3):758-66. PubMed ID: 15705872
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
[TBL] [Abstract][Full Text] [Related]
18. Regulation of ΔNp63α by NFκΒ.
Sen T; Chang X; Sidransky D; Chatterjee A
Cell Cycle; 2010 Dec; 9(24):4841-7. PubMed ID: 21088498
[TBL] [Abstract][Full Text] [Related]
19. DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.
Craig AL; Holcakova J; Finlan LE; Nekulova M; Hrstka R; Gueven N; DiRenzo J; Smith G; Hupp TR; Vojtesek B
Mol Cancer; 2010 Jul; 9():195. PubMed ID: 20663147
[TBL] [Abstract][Full Text] [Related]
20. Proteasome regulation of ULBP1 transcription.
Butler JE; Moore MB; Presnell SR; Chan HW; Chalupny NJ; Lutz CT
J Immunol; 2009 May; 182(10):6600-9. PubMed ID: 19414815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
